Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Lutein and Zeaxanthin-Food Sources, Bioavailability  and Dietary Variety in Age-Related Macular  Degeneration Protection.

Eisenhauer B, Natoli S, Liew G, Flood VM.

Nutrients. 2017 Feb 9;9(2). pii: E120. doi: 10.3390/nu9020120. Review.

PMID:
28208784
2.

Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.

Pennington KL, DeAngelis MM.

Eye Vis (Lond). 2016 Dec 22;3:34. doi: 10.1186/s40662-016-0063-5. eCollection 2016. Review.

PMID:
28032115
3.

SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY REVEALS CHORIOCAPILLARIS ALTERATIONS IN EYES WITH NASCENT GEOGRAPHIC ATROPHY AND DRUSEN-ASSOCIATED GEOGRAPHIC ATROPHY.

Moult EM, Waheed NK, Novais EA, Choi W, Lee B, Ploner SB, Cole ED, Louzada RN, Lu CD, Rosenfeld PJ, Duker JS, Fujimoto JG.

Retina. 2016 Dec;36 Suppl 1:S2-S11. doi: 10.1097/IAE.0000000000001287.

PMID:
28005659
4.

Repressed SIRT1/PGC-1α pathway and mitochondrial disintegration in iPSC-derived RPE disease model of age-related macular degeneration.

Golestaneh N, Chu Y, Cheng SK, Cao H, Poliakov E, Berinstein DM.

J Transl Med. 2016 Dec 20;14(1):344. doi: 10.1186/s12967-016-1101-8.

PMID:
27998274
5.

Proteomics-based identification and validation of novel plasma biomarkers phospholipid transfer protein and mannan-binding lectin serine protease-1 in age-related macular degeneration.

Kim HJ, Ahn SJ, Woo SJ, Hong HK, Suh EJ, Ahn J, Park JH, Ryoo NK, Lee JE, Kim KW, Park KH, Lee C.

Sci Rep. 2016 Sep 8;6:32548. doi: 10.1038/srep32548.

PMID:
27605007
6.

The Complement Regulatory Protein CD46 Deficient Mouse Spontaneously Develops Dry-Type Age-Related Macular Degeneration-Like Phenotype.

Lyzogubov VV, Bora PS, Wu X, Horn LE, de Roque R, Rudolf XV, Atkinson JP, Bora NS.

Am J Pathol. 2016 Aug;186(8):2088-104. doi: 10.1016/j.ajpath.2016.03.021. Epub 2016 Jun 11.

PMID:
27295359
7.

Visual Impairment and Blindness in Adults in the United States: Demographic and Geographic Variations From 2015 to 2050.

Varma R, Vajaranant TS, Burkemper B, Wu S, Torres M, Hsu C, Choudhury F, McKean-Cowdin R.

JAMA Ophthalmol. 2016 Jul 1;134(7):802-9. doi: 10.1001/jamaophthalmol.2016.1284.

PMID:
27197072
8.

Risk factors and biomarkers of age-related macular degeneration.

Lambert NG, ElShelmani H, Singh MK, Mansergh FC, Wride MA, Padilla M, Keegan D, Hogg RE, Ambati BK.

Prog Retin Eye Res. 2016 Sep;54:64-102. doi: 10.1016/j.preteyeres.2016.04.003. Epub 2016 May 6. Review.

PMID:
27156982
9.

VISUAL FUNCTION MEASURES IN EARLY AND INTERMEDIATE AGE-RELATED MACULAR DEGENERATION.

Chandramohan A, Stinnett SS, Petrowski JT, Schuman SG, Toth CA, Cousins SW, Lad EM.

Retina. 2016 May;36(5):1021-31. doi: 10.1097/IAE.0000000000001002.

PMID:
26925551
10.

Increased retinal mtDNA damage in the CFH variant associated with age-related macular degeneration.

Ferrington DA, Kapphahn RJ, Leary MM, Atilano SR, Terluk MR, Karunadharma P, Chen GK, Ratnapriya R, Swaroop A, Montezuma SR, Kenney MC.

Exp Eye Res. 2016 Apr;145:269-77. doi: 10.1016/j.exer.2016.01.018. Epub 2016 Feb 13.

PMID:
26854823
11.

Diffusion of anti-VEGF injections in the Portuguese National Health System.

Marques AP, Macedo AF, Perelman J, Aguiar P, Rocha-Sousa A, Santana R.

BMJ Open. 2015 Nov 23;5(11):e009006. doi: 10.1136/bmjopen-2015-009006.

PMID:
26597866
12.

Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration.

Brilliant MH, Vaziri K, Connor TB Jr, Schwartz SG, Carroll JJ, McCarty CA, Schrodi SJ, Hebbring SJ, Kishor KS, Flynn HW Jr, Moshfeghi AA, Moshfeghi DM, Fini ME, McKay BS.

Am J Med. 2016 Mar;129(3):292-8. doi: 10.1016/j.amjmed.2015.10.015. Epub 2015 Oct 30.

PMID:
26524704
13.

Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up.

Wu J, Cho E, Willett WC, Sastry SM, Schaumberg DA.

JAMA Ophthalmol. 2015 Dec;133(12):1415-24. doi: 10.1001/jamaophthalmol.2015.3590.

PMID:
26447482
14.

Phase ii, randomized, placebo-controlled, 90-day study of emixustat hydrochloride in geographic atrophy associated with dry age-related macular degeneration.

Dugel PU, Novack RL, Csaky KG, Richmond PP, Birch DG, Kubota R.

Retina. 2015 Jun;35(6):1173-83. doi: 10.1097/IAE.0000000000000606.

PMID:
25932553
15.

Combining macula clinical signs and patient characteristics for age-related macular degeneration diagnosis: a machine learning approach.

Fraccaro P, Nicolo M, Bonetto M, Giacomini M, Weller P, Traverso CE, Prosperi M, OSullivan D.

BMC Ophthalmol. 2015 Jan 27;15:10. doi: 10.1186/1471-2415-15-10.

PMID:
25623470
16.

Targeting Neovascularization in Ischemic Retinopathy: Recent Advances.

Al-Shabrawey M, Elsherbiny M, Nussbaum J, Othman A, Megyerdi S, Tawfik A.

Expert Rev Ophthalmol. 2013 Jun;8(3):267-286.

PMID:
25598837
17.

Prevalence and incidence of blindness and other degrees of sight impairment in patients treated for neovascular age-related macular degeneration in a well-defined region of the United Kingdom.

Buckle M, Lee A, Mohamed Q, Fletcher E, Sallam A, Healy R, Stratton I, Tufail A, Johnston RL.

Eye (Lond). 2015 Mar;29(3):403-8. doi: 10.1038/eye.2014.296. Epub 2015 Jan 16.

PMID:
25592123
18.

Zinc supplementation inhibits complement activation in age-related macular degeneration.

Smailhodzic D, van Asten F, Blom AM, Mohlin FC, den Hollander AI, van de Ven JP, van Huet RA, Groenewoud JM, Tian Y, Berendschot TT, Lechanteur YT, Fauser S, de Bruijn C, Daha MR, van der Wilt GJ, Hoyng CB, Klevering BJ.

PLoS One. 2014 Nov 13;9(11):e112682. doi: 10.1371/journal.pone.0112682. eCollection 2014.

PMID:
25393287
19.

Phonemic fluency and brain connectivity in age-related macular degeneration: a pilot study.

Whitson HE, Chou YH, Potter GG, Diaz MT, Chen NK, Lad EM, Johnson MA, Cousins SW, Zhuang J, Madden DJ.

Brain Connect. 2015 Mar;5(2):126-35. doi: 10.1089/brain.2014.0277. Epub 2014 Dec 2.

PMID:
25313954
20.

Projected changes in age-related macular degeneration and driving license holders in Finland.

Viitanen O, Arjamaa O.

Clin Ophthalmol. 2014 Sep 22;8:1913-7. doi: 10.2147/OPTH.S69246. eCollection 2014.

PMID:
25284977

Supplemental Content

Support Center